CORIXA CORP
S-8, EX-23.2, 2000-12-29
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CORIXA CORP, S-8, EX-5.1, 2000-12-29
Next: CORIXA CORP, S-8, EX-23.3, 2000-12-29



<PAGE>   1
                                                                    Exhibit 23.2


We consent to the incorporation by reference in the Registration Statement (Form
S-8) of Corixa Corporation pertaining to the Coulter Pharmaceutical, Inc. 1995
Equity Incentive Plan, Coulter Pharmaceutical, Inc. 1996 Equity Incentive Plan
and Coulter Pharmaceutical, Inc. 1996 Employee Stock Purchase Plan of our report
dated February 11, 2000, with respect to the consolidated financial statements
of Corixa Corporation included in its Annual Report (Form 10-K/A) for the year
ended December 31, 1999, filed with the Securities and Exchange Commission.


Seattle, Washington                                        Ernst & Young LLP
December 28, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission